4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors

被引：40

作者：

Ishida, J

Hattori, K

Yamamoto, H

Iwashita, A

Mihara, K

Matsuoka, N

机构：

[1] Med Chem Res Labs, Yodogawa Ku, Osaka 5328514, Japan

[2] Fujisawa Pharmaceut Co Ltd, Med Biol Res Labs, Yodogawa Ku, Osaka 5328514, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 19期

关键词：

PARP-1; poly(ADP-ribose) polymerase; 4-phenyl-1,2,3,6-tetrahydropyridine;

D O I：

10.1016/j.bmcl.2005.06.094

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We have shown that a 4-phenyl-1,2,3,6-tetrahydropyridine fragment plays an important role in improving inhibitory potency against poly(ADP-ribose) polymerise-1 (PARP-1). Various benzamide analogues linked with this fragment via alkyl spacers have been prepared and evaluated. As a result, some of them have been found to be highly potent PARP-1 inhibitors. (c) 2005 Elsevier Ltd. All rights reserved.

引用

收藏

页码：4221 / 4225

页数：5

相关论文

共 25 条

[11]

Kinoshita T, 2004, FEBS LETT, V556, P43, DOI 10.5940/jcrsj.46.421

[12] STUDIES IN BIOMIMETIC ALKALOID SYNTHESES .17. SYNTHESES OF IBOXYPHYLLINE AND RELATED ALKALOIDS [J].

KUEHNE, ME ;

PITNER, JB .

JOURNAL OF ORGANIC CHEMISTRY, 1989, 54 (19) :4553-4569

[13] Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats [J].

LaPlaca, MC ;

Zhang, J ;

Raghupathi, R ;

Li, JH ;

Smith, F ;

Bareyre, FM ;

Snyder, SH ;

Graham, DI ;

McIntosh, TK .

JOURNAL OF NEUROTRAUMA, 2001, 18 (04) :369-376

[14] Synthesis of substituted 5[H]phenanthridin-6-ones as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors [J].

Li, JH ;

Serdyuk, L ;

Ferraris, DV ;

Xiao, G ;

Tays, KL ;

Kletzly, PW ;

Li, WX ;

Lautar, S ;

Zhang, J ;

Kalish, VJ .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (13) :1687-1690

[15] Poly(ABP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism [J].

Mandir, AS ;

Przedborski, S ;

Jackson-Lewis, V ;

Wang, ZQ ;

Simbulan-Rosenthal, CM ;

Smulson, ME ;

Hoffman, BE ;

Guastella, DB ;

Dawson, VL ;

Dawson, TM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5774-5779

[16]

MEIJI, 2000, Patent No. 0042025

[17] Activation of poly(ADP-Ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia [J].

Nagayama, T ;

Simon, RP ;

Chen, DX ;

Henshall, DC ;

Pei, W ;

Stetler, RA ;

Chen, J .

JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) :1636-1645

[18] Phthalazine PDE4 inhibitors. Part 2: The synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives [J].

Napoletano, M ;

Norcini, G ;

Pellacini, F ;

Marchini, F ;

Morazzoni, G ;

Ferlenga, P ;

Pradella, L .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (01) :33-37

[19] Pharmacological modulation of poly(ADP-ribose) polymerase-mediated cell death:: Exploitation in cancer chemotherapy [J].

Nguewa, PA ;

Fuertes, MA ;

Alonso, C ;

Peréz, JM .

MOLECULAR PHARMACOLOGY, 2003, 64 (05) :1007-1014

[20] Poly(ADP-ribose) polymerase inhibitors [J].

Southan, GJ ;

Szabó, C .

CURRENT MEDICINAL CHEMISTRY, 2003, 10 (04) :321-340